Registered entities
Ray Therapeutics, Inc.
Reg. No. 862056423United States
Innovation
1 patent family — focus: Human necessities; filing pace active. Cited 17 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 7.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include 4Bio Capital, Novo Holdings, Janus Henderson Investors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 31% |
| Private equity | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 7 | 54% |
Hiring activity
Hires occasionally
2 roles tracked across 1 of the last 12 months
11 Mar 2026 · Associate Director, MS&T · Berkeley
4 Mar 2026 · Clinical Data Manager · Oakland
Based on job postings tracked across public sources.
Recent activity
2 Jul 2026
Leadership hire
Associate Director, MS&T
26 Jun 2026
Leadership hire
Executive Director, Patient Advocacy
16 Jun 2026
Event
Clinical Trials at Summit